Selected article for: "chronic kidney disease and symmetric dimethylarginine"

Title: RESEARCH COMMUNICATIONS OF THE 28th ECVIM-CA CONGRESS
  • Document date: 2018_12_19
  • ID: r79h9yzz_348
    Snippet: Sensitivity of serum creatinine (sCr) for detection of early chronic kidney disease is poor and its performance is even worse in hyperthyroidism due to poor muscle mass and hyperfiltration. Serum symmetric dimethylarginine (sSDMA) is a more sensitive renal biomarker in dogs and cats. A recent study showed relatively low sSDMA sensitivity (33.3%) in revealing masked azotemia in hyperthyroid cats. The objective of this study was to provide a shortâ.....
    Document: Sensitivity of serum creatinine (sCr) for detection of early chronic kidney disease is poor and its performance is even worse in hyperthyroidism due to poor muscle mass and hyperfiltration. Serum symmetric dimethylarginine (sSDMA) is a more sensitive renal biomarker in dogs and cats. A recent study showed relatively low sSDMA sensitivity (33.3%) in revealing masked azotemia in hyperthyroid cats. The objective of this study was to provide a short‐ and long‐term follow‐up of sSDMA and glomerular filtration rate (GFR) in hyperthyroid cats treated with radioiodine.

    Search related documents:
    Co phrase search for related documents